> top > docs > PubMed:24824948 > annotations

PubMed:24824948 JSONTXT

Annnotations TAB JSON ListView MergeView

sentences

Id Subject Object Predicate Lexical cue
TextSentencer_T1 0-164 Sentence denotes Hydrogen sulfide inhibits opioid withdrawal-induced pain sensitization in rats by down-regulation of spinal calcitonin gene-related peptide expression in the spine.
TextSentencer_T2 165-229 Sentence denotes Hyperalgesia often occurs in opioid-induced withdrawal syndrome.
TextSentencer_T3 230-491 Sentence denotes In the present study, we found that three hourly injections of DAMGO (a μ-opioid receptor agonist) followed by naloxone administration at the fourth hour significantly decreased rat paw nociceptive threshold, indicating the induction of withdrawal hyperalgesia.
TextSentencer_T4 492-634 Sentence denotes Application of NaHS (a hydrogen sulfide donor) together with each injection of DAMGO attenuated naloxone-precipitated withdrawal hyperalgesia.
TextSentencer_T5 635-830 Sentence denotes RT-PCR and Western blot analysis showed that NaHS significantly reversed the gene and protein expression of up-regulated spinal calcitonin gene-related peptide (CGRP) in naloxone-treated animals.
TextSentencer_T6 831-965 Sentence denotes NaHS also inhibited naloxone-induced cAMP rebound and cAMP response element-binding protein (CREB) phosphorylation in rat spinal cord.
TextSentencer_T7 966-1081 Sentence denotes In SH-SY5Y neuronal cells, NaHS inhibited forskolin-stimulated cAMP production and adenylate cyclase (AC) activity.
TextSentencer_T8 1082-1260 Sentence denotes Moreover, NaHS pre-treatment suppressed naloxone-stimulated activation of protein kinase C (PKC) α, Raf-1, and extracellular signal-regulated kinase (ERK) 1/2 in rat spinal cord.
TextSentencer_T9 1261-1457 Sentence denotes Our data suggest that H2S prevents the development of opioid withdrawal-induced hyperalgesia via suppression of synthesis of CGRP in spine through inhibition of AC/cAMP and PKC/Raf-1/ERK pathways.
T1 0-164 Sentence denotes Hydrogen sulfide inhibits opioid withdrawal-induced pain sensitization in rats by down-regulation of spinal calcitonin gene-related peptide expression in the spine.
T2 165-229 Sentence denotes Hyperalgesia often occurs in opioid-induced withdrawal syndrome.
T3 230-491 Sentence denotes In the present study, we found that three hourly injections of DAMGO (a μ-opioid receptor agonist) followed by naloxone administration at the fourth hour significantly decreased rat paw nociceptive threshold, indicating the induction of withdrawal hyperalgesia.
T4 492-634 Sentence denotes Application of NaHS (a hydrogen sulfide donor) together with each injection of DAMGO attenuated naloxone-precipitated withdrawal hyperalgesia.
T5 635-830 Sentence denotes RT-PCR and Western blot analysis showed that NaHS significantly reversed the gene and protein expression of up-regulated spinal calcitonin gene-related peptide (CGRP) in naloxone-treated animals.
T6 831-965 Sentence denotes NaHS also inhibited naloxone-induced cAMP rebound and cAMP response element-binding protein (CREB) phosphorylation in rat spinal cord.
T7 966-1081 Sentence denotes In SH-SY5Y neuronal cells, NaHS inhibited forskolin-stimulated cAMP production and adenylate cyclase (AC) activity.
T8 1082-1260 Sentence denotes Moreover, NaHS pre-treatment suppressed naloxone-stimulated activation of protein kinase C (PKC) α, Raf-1, and extracellular signal-regulated kinase (ERK) 1/2 in rat spinal cord.
T9 1261-1457 Sentence denotes Our data suggest that H2S prevents the development of opioid withdrawal-induced hyperalgesia via suppression of synthesis of CGRP in spine through inhibition of AC/cAMP and PKC/Raf-1/ERK pathways.

Allie

Id Subject Object Predicate Lexical cue
SS1_24824948_4_0 763-794 expanded denotes calcitonin gene-related peptide
SS2_24824948_4_0 796-800 abbr denotes CGRP
SS1_24824948_5_0 885-922 expanded denotes cAMP response element-binding protein
SS2_24824948_5_0 924-928 abbr denotes CREB
SS1_24824948_6_0 1049-1066 expanded denotes adenylate cyclase
SS2_24824948_6_0 1068-1070 abbr denotes AC
SS1_24824948_7_0 1156-1172 expanded denotes protein kinase C
SS2_24824948_7_0 1174-1177 abbr denotes PKC
SS1_24824948_7_1 1193-1230 expanded denotes extracellular signal-regulated kinase
SS2_24824948_7_1 1232-1235 abbr denotes ERK
AE1_24824948_4_0 SS1_24824948_4_0 SS2_24824948_4_0 abbreviatedTo calcitonin gene-related peptide,CGRP
AE1_24824948_5_0 SS1_24824948_5_0 SS2_24824948_5_0 abbreviatedTo cAMP response element-binding protein,CREB
AE1_24824948_6_0 SS1_24824948_6_0 SS2_24824948_6_0 abbreviatedTo adenylate cyclase,AC
AE1_24824948_7_0 SS1_24824948_7_0 SS2_24824948_7_0 abbreviatedTo protein kinase C,PKC
AE1_24824948_7_1 SS1_24824948_7_1 SS2_24824948_7_1 abbreviatedTo extracellular signal-regulated kinase,ERK

DisGeNET5_gene_disease

Id Subject Object Predicate Lexical cue
24824948-2#72#89#gene4988 302-319 gene4988 denotes μ-opioid receptor
24824948-2#248#260#diseaseC0020429 478-490 diseaseC0020429 denotes hyperalgesia
24824948-8#177#182#gene5894 1438-1443 gene5894 denotes Raf-1
24824948-8#177#182#gene6037 1438-1443 gene6037 denotes Raf-1
24824948-8#177#182#gene5894 1438-1443 gene5894 denotes Raf-1
24824948-8#177#182#gene6037 1438-1443 gene6037 denotes Raf-1
24824948-8#54#71#diseaseC0029104 1315-1332 diseaseC0029104 denotes opioid withdrawal
24824948-8#80#92#diseaseC0020429 1341-1353 diseaseC0020429 denotes hyperalgesia
72#89#gene4988248#260#diseaseC0020429 24824948-2#72#89#gene4988 24824948-2#248#260#diseaseC0020429 associated_with μ-opioid receptor,hyperalgesia
177#182#gene589454#71#diseaseC0029104 24824948-8#177#182#gene5894 24824948-8#54#71#diseaseC0029104 associated_with Raf-1,opioid withdrawal
177#182#gene589480#92#diseaseC0020429 24824948-8#177#182#gene5894 24824948-8#80#92#diseaseC0020429 associated_with Raf-1,hyperalgesia
177#182#gene603754#71#diseaseC0029104 24824948-8#177#182#gene6037 24824948-8#54#71#diseaseC0029104 associated_with Raf-1,opioid withdrawal
177#182#gene603780#92#diseaseC0020429 24824948-8#177#182#gene6037 24824948-8#80#92#diseaseC0020429 associated_with Raf-1,hyperalgesia
177#182#gene589454#71#diseaseC0029104 24824948-8#177#182#gene5894 24824948-8#54#71#diseaseC0029104 associated_with Raf-1,opioid withdrawal
177#182#gene589480#92#diseaseC0020429 24824948-8#177#182#gene5894 24824948-8#80#92#diseaseC0020429 associated_with Raf-1,hyperalgesia
177#182#gene603754#71#diseaseC0029104 24824948-8#177#182#gene6037 24824948-8#54#71#diseaseC0029104 associated_with Raf-1,opioid withdrawal
177#182#gene603780#92#diseaseC0020429 24824948-8#177#182#gene6037 24824948-8#80#92#diseaseC0020429 associated_with Raf-1,hyperalgesia

DisGeNet-2017-sample

Id Subject Object Predicate Lexical cue
T2668 1438-1443 gene:5894 denotes Raf-1
T2669 1315-1332 disease:C0029104 denotes opioid withdrawal
T2670 1341-1353 disease:C0020429 denotes hyperalgesia
R1 T2668 T2669 associated_with Raf-1,opioid withdrawal
R2 T2668 T2669 associated_with Raf-1,opioid withdrawal
R3 T2668 T2670 associated_with Raf-1,hyperalgesia
R4 T2668 T2670 associated_with Raf-1,hyperalgesia

UBERON-AE

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 953-964 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord
PD-UBERON-AE-B_T2 1248-1259 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord

performance-test

Id Subject Object Predicate Lexical cue
PD-UBERON-AE-B_T1 977-985 http://purl.obolibrary.org/obo/UBERON_2000602 denotes neuronal
PD-UBERON-AE-B_T2 953-964 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord
PD-UBERON-AE-B_T3 1248-1259 http://purl.obolibrary.org/obo/UBERON_0002240 denotes spinal cord